birb 796 has been researched along with 2-((4-pyridyl)methyl)amino-n-(3-(trifluoromethyl)phenyl)benzamide in 1 studies
| Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) | Studies (2-((4-pyridyl)methyl)amino-n-(3-(trifluoromethyl)phenyl)benzamide) | Trials (2-((4-pyridyl)methyl)amino-n-(3-(trifluoromethyl)phenyl)benzamide) | Recent Studies (post-2010) (2-((4-pyridyl)methyl)amino-n-(3-(trifluoromethyl)phenyl)benzamide) |
|---|---|---|---|---|---|
| 137 | 5 | 80 | 17 | 0 | 3 |
| Protein | Taxonomy | birb 796 (IC50) | 2-((4-pyridyl)methyl)amino-n-(3-(trifluoromethyl)phenyl)benzamide (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 2.82 | |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 0.38 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.64 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.236 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.1365 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.018 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0506 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gray, NS; Liu, Y | 1 |
1 other study(ies) available for birb 796 and 2-((4-pyridyl)methyl)amino-n-(3-(trifluoromethyl)phenyl)benzamide
| Article | Year |
|---|---|
Rational design of inhibitors that bind to inactive kinase conformations.
Topics: Binding Sites; Drug Design; Humans; Models, Molecular; Phosphotransferases; Protein Kinase Inhibitors; Protein Structure, Tertiary | 2006 |